<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Joyce LR</submitter><funding>NIAID NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>eadn7848</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11135403</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(22)</volume><pubmed_abstract>&lt;i>Streptococcus agalactiae&lt;/i> [group B &lt;i>Streptococcus&lt;/i> (GBS)] is a leading cause of neonatal meningitis, with late-onset disease (LOD) occurring after gastrointestinal tract colonization in infants. Bacterial membrane lipids are essential for host-pathogen interactions, and the functions of glycolipids are yet to be fully elucidated. GBS synthesizes three major glycolipids: glucosyl-diacylglycerol (Glc-DAG), diglucosyl-DAG (Glc&lt;sub>2&lt;/sub>-DAG), and lysyl-Glc-DAG (Lys-Glc-DAG). Here, we identify the enzyme, IagB, as responsible for biosynthesis of Glc-DAG, the precursor for the two other glycolipids in GBS. To examine the collective role of glycolipids to GBS virulence, we adapted a murine model of neonatal meningitis to simulate LOD. The GBS∆&lt;i>iagB&lt;/i> mutant traversed the gut-epi</pubmed_abstract><journal>Science advances</journal><pubmed_title>&amp;lt;i&amp;gt;Streptococcus agalactiae&amp;lt;/i&amp;gt; glycolipids promote virulence by thwarting immune cell clearance.</pubmed_title><pmcid>PMC11135403</pmcid><funding_grant_id>R01 AI153332</funding_grant_id><funding_grant_id>R01 AI178692</funding_grant_id><funding_grant_id>R01 NS116716</funding_grant_id><funding_grant_id>R01 NS098273</funding_grant_id><funding_grant_id>R01 AI148366</funding_grant_id><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Doran KS</pubmed_authors><pubmed_authors>Guan Z</pubmed_authors><pubmed_authors>Christensen PM</pubmed_authors><pubmed_authors>Joyce LR</pubmed_authors><pubmed_authors>Spencer BL</pubmed_authors><pubmed_authors>Palmer KL</pubmed_authors><pubmed_authors>Siegenthaler JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>&amp;lt;i&amp;gt;Streptococcus agalactiae&amp;lt;/i&amp;gt; glycolipids promote virulence by thwarting immune cell clearance.</name><description>&lt;i>Streptococcus agalactiae&lt;/i> [group B &lt;i>Streptococcus&lt;/i> (GBS)] is a leading cause of neonatal meningitis, with late-onset disease (LOD) occurring after gastrointestinal tract colonization in infants. Bacterial membrane lipids are essential for host-pathogen interactions, and the functions of glycolipids are yet to be fully elucidated. GBS synthesizes three major glycolipids: glucosyl-diacylglycerol (Glc-DAG), diglucosyl-DAG (Glc&lt;sub>2&lt;/sub>-DAG), and lysyl-Glc-DAG (Lys-Glc-DAG). Here, we identify the enzyme, IagB, as responsible for biosynthesis of Glc-DAG, the precursor for the two other glycolipids in GBS. To examine the collective role of glycolipids to GBS virulence, we adapted a murine model of neonatal meningitis to simulate LOD. The GBS∆&lt;i>iagB&lt;/i> mutant traversed the gut-epi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-03-11T00:06:06.503Z</modification><creation>2025-08-13T03:04:16.446Z</creation></dates><accession>S-EPMC11135403</accession><cross_references><pubmed>38809989</pubmed><doi>10.1126/sciadv.adn7848</doi></cross_references></HashMap>